Max Delbruck


Also found in: Dictionary, Thesaurus, Medical.

Delbrück, Max

(1906–81) geneticist, virologist; born in Berlin, Germany. Trained as a physicist, he performed research in Europe, where he devised mathematical proofs for the chemical bonding of lithium and published two scientific papers on quantum mechanics. He began his fundamental investigations on bacteria and their viruses (bacteriophages) after coming to the U.S.A. to join the California Institute of Technology (Caltech) (1937–39). He continued his bacteriophage research through his years at Vanderbilt University (1940–47), where he showed that viruses can recombine genetic material (1946). Delbruk returned to Caltech (1947–76), where he later turned his interest to sensory physiology. With fellow bacteriophage researchers Salvador Luria and Alfred Hershey, he won the 1969 Nobel Prize in physiology for his contributions to viral genetics.
The Cambridge Dictionary of American Biography, by John S. Bowman. Copyright © Cambridge University Press 1995. Reproduced with permission.
The following article is from The Great Soviet Encyclopedia (1979). It might be outdated or ideologically biased.

Delbrück, Max

 

Born Sept. 4, 1906, in Berlin. American physicist, geneticist, and virologist. Member of the US National Academy of Sciences.

A German by birth, Delbrück studied at the universities of Tubingen, Berlin, Bonn, and Göttingen from 1924 to 1930, receiving the degree of doctor of philosophy from the University of Göttingen. From 1932 to 1937 he worked at the Kaiser Wilhelm Institute. In 1937 he emigrated to the United States and worked at the California Institute of Technology (Pasadena, Calif.), where he became a professor of biology in 1947. His major works are devoted to nuclear physics, the analysis of spontaneous and induced mutations, bacteriophages, the physiology of the sense organs, and the quantum theory of the structure of chemical substances. For his work in the field of bacteriophages, Delbrück was awarded a Nobel Prize in 1969 (with A. Hershey and S. Luria).

WORKS

“Cosmic Rays and the Origin of Species.” Nature, 1936, vol. 137, p. 358. (With H. W. Timofeeff-Ressovsky.)
“On the Mechanism of DNA Replication.” (With G. S. Stent.) In the book Symposium on the Chemical Basis of Heredity. Edited by W. D. McElroy and B. Gloss. Baltimore, Md., 1957.
The Great Soviet Encyclopedia, 3rd Edition (1970-1979). © 2010 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
The team comprised scientists of INSERM, CNRS and MDC led by Michael Sieweke of the Centre d'Immunologie de Marseille Luminy and the Max Delbruck Centre for Molecular Medicine, Berlin-Buch.
Gary Lewin and colleagues at the Max Delbruck Center for Molecular Medicine in Berlin, Germany, gauged touch in 100 healthy pairs of fraternal and identical twins.
If mole rats had not evolved a way to ignore acid, the little rodents would be in constant agony, says Gary Lewin of the Max Delbruck Center for Molecular Medicine in Berlin, who led the new research with postdoctoral researcher Ewan St.
Carmen Birchmeier of the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch have shown that the stem cells weaken when, due to a mutation, they locate outside of the muscle fibers instead of in their stem cell niches.
Neurobiologists of the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch found that in mice in which they had removed the c-Maf gene in the nerve cells, touch sensation is impaired.
Walter Birchmeier and Torben Redmer from the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch, a member of the Helmholtz Association, used mouse embryonic fibroblasts (MEFs) in their stem cell experiments.
Washington, May 28 (ANI): Researchers of the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch have discovered a specific molecule that enables embryonic stem cells to differentiate into diverse cell types and thus to be pluripotent.
Walther of the Max Delbruck Center for Molecular Medicine in Berlin-Buch and his colleagues created mutant mice that lack this enzyme.
The Kidney Atlas was part of the European Renal Genome Project (EuReGene), coordinated by the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, which the European Union (EU) funded with more than 10 million euros.